Journey Medical CEO receives new equity awards
Journey Medical Corp reported that President & CEO Claude Maraoui received new equity awards as part of his compensation.
Rhea-AI Filing Summary
Journey Medical Corp reported that President & CEO Claude Maraoui received new equity awards as part of his compensation. On April 22, 2026, he was granted 49,277 restricted stock units that vest in three equal annual installments from 2027 through 2029.
He was also granted stock options for 82,915 shares at an exercise price of $5.04 per share, vesting on the same 2027–2029 schedule and expiring in 2036. Following these grants, Maraoui directly holds 2,435,990 shares of common stock and 82,915 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 132,192 shares
Grant/Award
2 txns
Insider
Maraoui Claude
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 82,915 | $0.00 | $0.00 |
| Grant/Award | Common Stock, $0.0001 par value | 49,277 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 82,915 contracts (Direct);
Common Stock, $0.0001 par value — 2,435,990 shares (Direct)
Footnotes (3)
- F1. On April 22, 2026, the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 16,426 shares on April 22, 2027, 16,426 shares on April 22, 2028 and 16,425 shares on April 22, 2029.
- F2. Includes restricted stock units, which vest over various time periods.
- F3. On April 22, 2026, the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 27,638 shares on April 22, 2027, 27,638 shares on April 22, 2028 and 27,639 shares on April 22, 2029.
Key Figures
RSUs granted: 49,277 units
RSU vesting schedule 2027: 16,426 units
RSU vesting schedule 2028: 16,426 units
+5 more
8 metrics
RSUs granted
49,277 units
Restricted stock units granted on April 22, 2026
RSU vesting schedule 2027
16,426 units
Vest on April 22, 2027
RSU vesting schedule 2028
16,426 units
Vest on April 22, 2028
RSU vesting schedule 2029
16,425 units
Vest on April 22, 2029
Stock options granted
82,915 options
Granted on April 22, 2026
Option exercise price
$5.04 per share
Exercise price for 82,915 options
Option expiration
April 22, 2036
Expiration date of granted options
Shares held after grant
2,435,990 shares
Common stock directly owned after April 22, 2026 grant
Key Terms
restricted stock units, stock options, 2015 Stock Plan, vesting, +1 more
5 terms
restricted stock units financial
"the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock options financial
"the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
2015 Stock Plan financial
"pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest"
vesting financial
"that will vest in accordance with the following schedule: 16,426 shares on April 22, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
par value financial
"Common Stock, $0.0001 par value"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Journey Medical (DERM) report for Claude Maraoui?
Journey Medical reported that President & CEO Claude Maraoui received equity compensation, including 49,277 restricted stock units and 82,915 stock options. These awards were granted on April 22, 2026 under the company’s 2015 Stock Plan, reflecting routine executive incentive grants rather than open-market trades.
How many restricted stock units did the Journey Medical (DERM) CEO receive?
Claude Maraoui received 49,277 restricted stock units. According to the grant terms, 16,426 units vest on April 22, 2027, another 16,426 vest on April 22, 2028, and the remaining 16,425 vest on April 22, 2029, subject to plan conditions being satisfied.
What stock options were granted to the Journey Medical (DERM) CEO?
Maraoui was granted stock options for 82,915 shares of Journey Medical common stock at an exercise price of $5.04 per share. These options vest in three annual tranches from 2027 to 2029 and expire on April 22, 2036, providing long-term equity-based compensation.
When do the new Journey Medical (DERM) CEO equity awards vest?
Both the restricted stock units and stock options granted on April 22, 2026 vest over three years. RSUs and options vest in tranches on April 22, 2027, April 22, 2028, and April 22, 2029, aligning the CEO’s incentives with multi-year company performance.
Are the Journey Medical (DERM) CEO’s new awards open-market purchases or compensation grants?
The Form 4 shows these are compensation-related grants, not open-market trades. Both the 49,277 restricted stock units and the 82,915 stock options are classified as awards under the company’s 2015 Stock Plan, with no purchase price paid per share at grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
